S.B. 78
         PHARMACY ACT AMENDMENTS

Senate Floor Amendments

Amendment 2 March 6, 2013 12:07 PM



Senator Evan J. Vickers proposes the following amendments:

1.    Page 2, Line 45 :    

             45          58-17b-605, as last amended by Laws of Utah 2008, Chapter 205
      63I-2-258, as last amended by Laws of Utah 2012, Chapters 88 and 369      


2.    Page 17, Lines 510 through 516
    Senate Committee Amendments
    2-21-2013 :
    

             510          (8)
  (a)       A pharmacist or pharmacy intern who substitutes an interchangeable biosimilar

             511      product for a prescribed biological product shall:
             512          
{   (a)   }        (i)       notify the prescriber in writing S. , by fax, telephone, or electronic transmission .S

             512a      of the substitution, as soon as practicable, but not
             513      later than three business days after dispensing the interchangeable biosimilar product in place
             514      of the prescribed biological product; and
             515          
{   (b)   }        (ii)       include the name and manufacturer of the interchangeable biosimilar product

             516      substituted.
  (b) This subsection is repealed on July 1, 2015.      


3.    Page 17, Line 521
    Senate Committee Amendments
    2-21-2013 :
    

             521      authorized does not constitute evidence of negligence.
    
  Section 4. Section 63I-2-258 is amended to read:      

     63I-2-258 .   Repeal dates -- Title 58.
     (1) Subsection 58-72-201 (1)(b) is repealed July 1, 2014.
    
  (2) Subsection 58-17b-606.5(8) is repealed on July 1, 2015.      


Renumber remaining sections accordingly.


Page 1 of 1
LRGC ajacobson ajacobson